Tarsus Pharmaceuticals, Inc. earnings per share and revenue

TARS earnings per share for the last quarter are -0.88 USD whereas the estimation was -0.92 USD which accounts for 4.66% surprise. Company revenue for the same period amounts to 40.81 M USD despite the estimated figure of 32.33 M USD. Estimated earnings per share for the next quarter are -0.94 USD, and revenue is expected to reach 43.18 M USD. Also watch annual changes over time to get a bigger picture of TARS earnings per share and revenue dynamics.